Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bulow BioTech Prosthetics, a provider of customized one-on-one patient care to amputee patients in the US, has secured new financing from Nashville-based Frist Capital.
Subscribe to our email newsletter
The new capital will be used for growth initiatives and general corporate purposes.
Frist Capital is a private investment company investing the assets of a Nashville family.
Matthew Bulow, founder and chief clinical officer of Bulow BioTech, said: “This investment furthers our mission of becoming one of the world’s leading patient care providers for prosthetic applications and helping our patients live their lives to the fullest.”